Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NexGen Hyperbaric is a U.S. healthcare company focused on delivering medical-grade hyperbaric oxygen therapy (HBOT) through outpatient clinics, hospital-based programs, and proprietary mobile treatment units. The company serves professional sports teams, hospitals, research organizations, and individual patients, positioning itself as a national provider of hyperbaric medicine rather than a drug developer. Its offerings center on physician-supervised, UHMS-accredited or accreditation-oriented HBOT services for wound healing, sports recovery, neurological injury, and other acute or chronic conditions. NexGen also operates alongside The Center for Wound Healing & Hyperbaric Medicine to support hospital partners with on-site wound care and hyperbaric programs. The business appears to be commercial-stage and service-driven, with growth tied to facility expansion, sports partnerships, and broader access to mobile hyperbaric care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NexGen Hyperbaric.